← Oncology Approval Tracker

FDA DECISION ·

Pomalidomide (Pomalyst first generics)

pomalidomide · Breckenridge Pharmaceutical and Eugia Pharma Specialties

First generic approvalFirst genericMultiple myeloma and Kaposi sarcoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Two first generic Pomalyst approvals for the same capsule strengths, covering selected adults with multiple myeloma with dexamethasone and adults with AIDS-related Kaposi sarcoma after antiretroviral failure or Kaposi sarcoma without HIV.

LAMPGEN ANALYSIS

Why it matters

Added generic applications for an oral agent used in hematologic and solid tumor care.

What research teams should watch

Check actual availability independently of approval and maintain required risk-management procedures.

PRIMARY RECORDS

Sources